Floatz logo

299 assets in Lung Cancer

Therapeutic assets addressing Lung Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Regorafenib
Lung Cancer
Incyte CorporationP2CCC (48)
Riluzole
Lung Cancer
University of California, IrvineP2CCC (48)
Rmc-6236
Lung Cancer
Tango Therapeutics, Inc.P1/2CCC (48)
Rmc-9805
Lung Cancer
Tango Therapeutics, Inc.P1/2CCC (48)
Ruxolitinib
Lung Cancer
Incyte CorporationP2CCC (48)
SLC391
Lung Cancer
SignalChem Lifesciences CorporationP1/2CCC (48)
Tafolecimab
Lung Cancer
Jinghui WangP2CCC (48)
Trastuzumab Emtansine
Lung Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (48)
Trilaciclib
Lung Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Vebreltinib
Lung Cancer
Apollomics Inc.P2CCC (48)
Volitinib
Lung Cancer
Sun Yat-sen UniversityP2CCC (48)
ans014004
Lung Cancer
Beijing Pearl Biotechnology Limited Liability CompanyP1/2CC (47)
Devimistat
Lung Cancer
Northwestern UniversityP2CC (47)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Lung Cancer
M.D. Anderson Cancer CenterP2CC (47)
plb1004
Lung Cancer
Beijing Pearl Biotechnology Limited Liability CompanyP1/2CC (47)
s241656
Lung Cancer
Institut de Recherches Internationales ServierP1/2CC (47)
Silevertinib
Lung Cancer
Black Diamond Therapeutics, Inc.P1/2CC (47)
Trastuzumab Deruxtecan
Lung Cancer
National Cancer Institute (NCI)P1/2CC (47)
Cea Car-T Cells
Lung Cancer
Chongqing Precision Biotech Co., LtdP1/2CC (46)
Cea-Targeted Car-T
Lung Cancer
Chongqing Precision Biotech Co., LtdP1/2CC (46)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Lung Cancer
Bristol-Myers SquibbP1/2CC (46)
Nazartinib
Lung Cancer
SWOG Cancer Research NetworkP2CC (46)
Trabedersen
Lung Cancer
University of WashingtonP2CC (46)
Vorinostat
Lung Cancer
H. Lee Moffitt Cancer Center and Research InstituteP1/2CC (46)
Aurora A Kinase Inhibitor Ly3295668
Lung Cancer
M.D. Anderson Cancer CenterP1/2CC (45)
Bafisontamab
Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.P1/2CC (45)
bnt324
Lung Cancer
BioNTech SEP1/2CC (45)
bnt327
Lung Cancer
BioNTech SEP1/2CC (45)
Iadademstat
Lung Cancer
National Cancer Institute (NCI)P1/2CC (45)
Immunoglobulin G1 [351-Alanine,386-Alanine,387-Alanine] Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Imm2902 ?1-Chain), Disulfide With 1-125-Signal Regulatory Protein ? [80-Alanine] (Human Isoform 4 Variant) Fusion Protein With Peptide Linker ((Ggggs)3) Fusion Protein With Human-Mus Musculus Monoclonal Imm2902 ?-Chain, Dimer
Lung Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1/2CC (45)
tno155
Lung Cancer
Novartis PharmaceuticalsP1/2CC (45)
18F-ASIS
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1CC (44)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Lung Cancer
Kineta Inc.P1/2CC (44)
[99mTc]Tc-HYNIC-FAPI
Lung Cancer
Tomsk National Research Medical Center of the Russian Academy of SciencesP1CC (43)
an0025
Lung Cancer
Rutgers, The State University of New JerseyP1CC (43)
Bbo-10203
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P1CC (43)
Bbo-8520
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P1CC (43)
Carfilzomib
Lung Cancer
City of Hope Medical CenterP1CC (43)
cpo301
Lung Cancer
Conjupro Biotherapeutics, Inc.P1CC (43)
Crpa1A2
Lung Cancer
Corregene Biotechnology Co., LtdP1CC (43)
Hafnium Oxide
Lung Cancer
M.D. Anderson Cancer CenterP1CC (43)
IPH5301
Lung Cancer
Institut Paoli-CalmettesP1CC (43)
Papaverine
Lung Cancer
Ohio State University Comprehensive Cancer CenterP1CC (43)
Pebezertinib
Lung Cancer
Blueprint Medicines CorporationP1CC (43)
Ribociclib
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)P1CC (43)
SAR443216
Lung Cancer
SanofiP1CC (43)
Super1 Tcr-T
Lung Cancer
Guangzhou FineImmune Biotechnology Co., LTD.P1CC (43)
sv-101
Lung Cancer
Williams Cancer FoundationP1CC (43)
Vedolizumab
Lung Cancer
M.D. Anderson Cancer CenterP1CC (43)
[111in]-fpi-1967
Lung Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
Showing 151 to 200 of 299 assets
PreviousPage 4 of 6Next